| Screen-detected diabetes | Non-diabetic hyperglycaemia | |||||
|---|---|---|---|---|---|---|
| RC( n = 669) | IT( n = 524) | IT +MI( n = 422) | RC( n = 1193) | IT( n = 863) | IT +MI( n = 599) | |
| Male sex, n (%) | 372 (55.6) | 302 (57.6) | 244 (57.8) | 581 (48.7) | 438 (50.8) | 309 (51.6) |
| Mean age ( SD ) | 59.9 (6.8) | 59.4 (7.1) | 59.8 (7.0) | 59.8 (6.9) | 60.3 (6.4) | 60.5 (6.6) |
| Education level, n (%) | ||||||
| 0–10 years | 246 (37.5) | 203 (39.6) | 151 (36.4) | 475 (40.7) | 331 (39.2) | 199 (34.1) |
| 10–15 years | 288 (43.9) | 214 (41.8) | 182 (43.9) | 464 (39.8) | 350 (41.5) | 242 (41.4) |
| > 15 years | 122 (18.6) | 95 (18.6) | 82 (19.8) | 227 (19.5) | 163 (19.3) | 143 (24.5) |
| Previous CVD, n (%) | 36 (5.4) | 51 (9.7) | 30 (7.1) | 91 (7.6) | 57 (6.6) | 36 (6.0) |
| Redeemed anti hypertensive medication, n (%) | ||||||
| Year 2000 | 242 (36.2) | 188 (35.9) | 157 (37.2) | 369 (30.9) | 258 (29.9) | 208 (34.7) |
| Year 2005 | 436 (66.6) | 351 (68.7) | 325 (79.7) | 613 (52.3) | 404 (47.9) | 309 (53.4) |
| Year 2010 | 503 (82.7) | 415 (85.9) | 333 (89.8) | 733 (66.3) | 518 (65.9) | 398 (72.2) |
| Redeemed glucose-lowering medication, n (%) | ||||||
| Year 2000 | a | a | 0 (0.0) | 0 (0.0) | 0 (0.0) | a |
| Year 2005 | 173 (26.4) | 177 (34.6) | 181 (44.4) | 27 (2.3) | 23 (2.7) | 22 (3.8) |
| Year 2010 | 354 (58.2) | 315 (65.2) | 260 (70.1) | 161 (14.6) | 111 (14.1) | 79 (14.3) |
| Redeemed lipid-lowering medication, n (%) | ||||||
| Year 2000 | 45 (6.7) | 37 (7.1) | 21 (5.0) | 58 (4.9) | 45 (5.2) | 32 (5.3) |
| Year 2005 | 319 (48.7) | 320 (62.6) | 282 (69.1) | 282 (24.0) | 203 (24.1) | 148 (25.6) |
| Year 2010 | 454 (74.7) | 406 (84.1) | 309 (83.3) | 495 (44.8) | 360 (45.8) | 273 (49.5) |
| CVD events during follow-up, n (%) | 116 (17.3) | 98 (18.7) | 93 (22.0) | 221 (18.5) | 143 (16.6) | 120 (20.0) |
| Deaths during follow-up, n (%) | 93 (13.9) | 62 (11.8) | 64 (15.2) | 126 (10.6) | 107 (12.4) | 65 (10.9) |
| HR for CVD ( 95% CI ) | – | 1.11 (0.82 to 1.50) | 1.26 (0.96 to 1.64) | – | 0.92 (0.74 to 1.14) | 1.00 (0.80 to 1.26) |
| HR for all-cause mortality ( 95% CI ) | – | 0.88 (0.61 to 1.27) | 1.02 (0.74 to 1.39)l | – | 1.23 (0.95 to 1.60) | 0.88 (0.65 to 1.19) |
CI = confidence intervals. CVD =cardiovascular disease. HR = hazard ratio. IT = intensive treatment. MI = motivational interviewing. RC = routine care. SD = standard deviation.
↵ aNumbers too small to report (Denmark Statistics regulations).
Some percentages may not add up to expected total due to reducing cohort size over time and a small amount of missing data for some variables.